Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
38 hedge funds and large institutions have $4M invested in Nymox Pharmaceutical Corp in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 13 closing their positions.
95% more call options, than puts
Call options by funds: $74K | Put options by funds: $38K
1% less capital invested
Capital invested by funds: $4.03M → $4M (-$35.2K)
25% less funds holding
Funds holding: 51 → 38 (-13)
63% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 16
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$247K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$97.6K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$32.1K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$16.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$451K |
| 2 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$239K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$117K |
| 4 |
Jane Street
New York
|
-$67K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$57K |
NYMX Hedge Fund Activity: Q3 2021 in Review
38 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2021, worth a combined $4M — down 0.87% from $4.03M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NYMX and 1 opened new positions — a net loss of 12 holders — while 16 trimmed existing stakes and 6 added.
The largest buyer was Private Advisor Group, adding an estimated $247K. The largest seller was Millennium Management, cutting an estimated $451K.
- 38 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2021, down from 51 in Q2 2021.
- Funds reported $4M of Nymox Pharmaceutical Corp stock for Q3 2021, down 0.87% quarter-over-quarter.
- 1 fund opened new Nymox Pharmaceutical Corp positions in Q3 2021 and 13 closed out, a net change of -12 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q3 2021 was Private Advisor Group, an estimated $247K added.
- The largest Nymox Pharmaceutical Corp seller in Q3 2021 was Millennium Management, an estimated $451K sold.
Based on aggregated 13F filings for Q3 2021.